TRIIM Treatment
AssetAlso TRIIM
Regimen of recombinant human growth hormone, DHEA, and metformin for thymus regeneration
- Stage
- Phase 2
- Modality
- Other
- Target
- Epigenetic regulation of gene expression
- 2
- Indications
- 1
- Trial
- 1
- Developer
Indications
2Epigenetic aging
Phase 2, Recruiting, NCT04375657, clinicaltrials.gov, 7 Oct 2026
Immunosenescence
Phase 2, Recruiting, NCT04375657, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains2
- Owner and partners1
- Trials1
- Evidence for its targets2
- Competitors12
- Aging relevance3
Every asset’s record: target, stage, trials and the evidence behind it.
Updated 7 Oct 2026, 1 source